Cite
HARVARD Citation
Ren, P. et al. (2018). Interferon-based treatment is superior to nucleos(t)ide analog in reducing HBV-related hepatocellular carcinoma for chronic hepatitis B patients at high risk. Expert opinion on biological therapy. pp. 1085-1094. [Online].